Table 4.
Treatments | Thiol content | CAT | ||||
---|---|---|---|---|---|---|
Liver | Brain | Kidney | Liver | Brain | Kidney | |
Data are reported as mean ± SEM (n = 6) and assessed by one way ANOVA followed by Duncan Multiple Comparison post hoc test. Results are presented as mmol NPSH (non-protein thiol)/mg protein and units of catalase (CAT)/mg protein. (*) and (**) denotes p < 0.05 and p < 0.001, respectively, as compared to the respective control samples. (#), (##) and (###) denotes p < 0.05, p < 0.001 and p < 0.0001, respectively, as compared to the respective induced samples. | ||||||
Control | 11.16 ± 2.16 | 7.57 ± 1.01 | 5.66 ± 1.19 | 38.14 ± 6.49 | 6.36 ± 1,49 | 17.71 ± 2.22 |
Gallic acid 25 µg/mL | 11.44 ± 2.6 | 9.85 ± 0.29 | 7.31 ± 0.78 | 40.28 ± 9.87 | 6.34 ± 0.34 | 26.53 ± 1.53 * |
Syzygium jambos 100 µg/mL | 7.41 ± 0.84 | 9.12 ± 0.50 | 6.21 ± 1.81 | 37.65 ± 7.81 | 4.16 ± 1.25 | 15.41 ± 2.75 |
Syzygium jambos 250 µg/mL | 7.32 ± 1.89 | 10.66 ± 0.73 | 9.73 ± 1.36 | 28.72 ± 6.54 | 2.80 ± 1.10 | 13.84 ± 2.33 |
Solanum guaraniticum 500 µg/mL | 6.42 ± 1.82 | 9.20 ± 1.00 | 10.52 ± 1.76 * | 41.98 ± 6.18 | 3.43 ± 1.07 | 20.80 ± 2.03 |
Solanum guaraniticum 1000 µg/mL | 10.94 ± 2.35 | 10.91 ± 1.69 | 8.84 ± 0.20 | 49.10 ± 6.45 | 3.37 ± 1.17 | 18.82 ± 1.65 |
Induced (SNP) | 4.84 ± 1.69 * | 2.64 ± 0.57 ** | 5.42 ± 1.70 | 46.78 ± 9.98 | 4.04 ± 1.17 | 16.74 ± 1.01 |
Gallic acid 25 µg/mL | 5.51 ± 0.57 | 3,01 ± 0.20 | 5.43 ± 0.54 | 53.47 ± 10.44 | 2.95 ± 0.56 | 26.52 ± 3.08 # |
Syzygium jambos 100 µg/mL + SNP | 5.80 ± 1.46 | 7.52 ± 0.79 ## | 6.13 ± 1.00 | 48.04 ± 7.70 | 4.13 ± 1.42 | 17.92 ± 1.52 |
Syzygium jambos 250 µg/mL + SNP | 6.66 ± 0.90 | 9.40 ± 0.65 ### | 10.56 ± 1.96 # | 40.04 ± 9.82 | 2.37 ± 1.37 | 19.47 ± 3.23 |
Solanum guaraniticum 500 µg/mL + SNP | 8.45 ± 1.87 | 7.30 ± 0.52 ## | 6.95 ± 0.62 | 47.69 ± 13.39 | 4.17 ± 1.01 | 19.18 ± 1.17 |
Solanum guaraniticum 1000 µg/mL + SNP | 7.96 ± 1.67 | 9.03 ± 0.86 ### | 9.50 ± 1.51 | 41.60 ± 11.14 | 3.52 ± 1.06 | 19.18 ± 1.69 |